This content is from: Premium

Inside the Trade: Addicted to Allergan

The Allergan-Valeant takeover saga may be long over, but there’s still some life left in the trade.

       Illustration by The Project Twins When the smoke finally cleared from the epic Allergan-­Valeant takeover battle, everybody walked away richer, from Pershing Square Capital Management’s Bill Ackman to Och-Ziff Capital Management Group’s Dan Och to Paulson & Co.’s John Paulson — to name just three of the many managers who played some angle

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content